In order to avoid the appearance of antimicrobial resistance we usually start antimicrobial empirical therapy based on the most probable bacteria despite knowing that we won´t be covering 100% of pathogens (sometimes probably not even 80%).

Don't you think there is a dilemma between not offering 100% coverage versus preventing the emergence of resistance in the near future?

More Alex Smithson's questions See All
Similar questions and discussions